SDF-1α, a prognostic protein marker in synovial fluids for PTOA in ACL deficient knees?  by Ding, Lei et al.
90 Session: Disease & Treatmenttrabecular bone number (Tb.N), trabecular bone thickness (Tb.Th) and trabecular
bone separation (Tb.Sp) were analyzed for evaluation of bone quality and micro-
architecture. For confirming the specificity of the targeting delivery system, we
usedXenogen IVIS spectrumto semi-qualify the distributionof bone targeting system
signals in vivo by injecting labelled targeting delivery system into four-month-old
C57/BL6 normal female mice.
Results: From the micro-CT results, by comparing to the OVX group, bone quality
in groups with IV injection were enhanced reflected in the increased BMD
(p<0.05), bone volume (p<0.05), trabecular bone number and connectivity den-
sity (p<0.05) and decreased in trabecular bone separation (p<0.05). Also the
efficacy of the targeting Icaritin delivery system tended to be dosage dependent
(BV increased 14.16% in high dose group, Tb.N increased 10.34% and connectivity
density of trabecular bone increased 19.70%). Moreover from the Structure Model
Index (SMI) value, we conclude that the morphology of trabecular bone in Icaritin
injection groups tended more to be plate-like: SMI (OVX) Z 2.190.30, SMI
(IV-AP8+LPS+ICT-1) Z 2.070.36, SMI (IV-AP8+LPS+ICT-H) Z 2.010.23). From
the organ distribution map of Xenogen IVIS spectrum, there were more signals
retain in bone 72 hours after injection by comparing to the delivery system
without bone targeting DSS6.
Discussion and Conclusion: The novel bone-targeting delivery system carrying
osteopromotive phytomolecule Icaritin was confirmed to be capable of preventing
oestrogen depletion-induced osteoporosis in a dose dependent manner.
http://dx.doi.org/10.1016/j.jot.2016.06.06784
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Introduction: Osteoarthritis (OA) is the most common chronic condition of the
joints affecting approximately 27 million adults in the United States alone. The su-
perficial layer of mature articular cartilage is the first line of defence against OA
initiation. It has 2e4 layers of flat cells expressing unique molecules, such as pro-
teoglycan 4 (Prg4, lubricin) and contains a fine network of collagen fibrils that are
oriented horizontally and parallel to the articular surface [1]. Its multifaceted
roles include, but are not limited to, producing lubricant proteins, harbouring
chondroprogenitors, resisting shear stresses, serving as a gliding surface, and
isolating deeper layers from synovial fluid [1]. In OA, degenerative changes initiate
with cellular disorganization, gradual stiffening, and irregular surface of this layer
[2e4]. Despite the critical role of superficial chondrocytes in maintaining articular
cartilage and in preventing OA, its regulation by growth factors and hormones are
still largely unknown.
Objective: To investigate the function of epidermal growth factor receptor (EGFR)
in articular cartilage development and osteoarthritis (OA) progression in geneti-
cally modified and surgical mouse models.
Methods: Animals and surgery- Cartilage-specific Egfr CKO (Col2-Cre EgfrWa5/f)
mice and their Wa5 (EgfrWa5/f) and wild-type (WT, Col2-Cre Egfrf/+ and Egfrf/
+) siblings were generated by breeding Col2a1-Cre, EgfrWa5/+, and Egfrf/f
mice. EgfrWa5 codes for a kinase-dead, dominant negative receptor. To induce
OA, male mice at three months of age were subjected to destabilization of the
medial meniscus (DMM) surgery at the right knees and sham surgery at the left
knees. Their knee joints were examined by histology, immunohistochemistry,
nano-indentation, and microCT with or without destabilization of the medial
meniscus (DMM) surgery. Primary chondrocytes were used to study the direct ef-
fects of activating EGFR on chondrocytes. Finite element models were built to
calculate the mechanical loading on cartilage and subchondral bone plate (SBP) af-
ter DMM.Results: EGFR activity is more dominant in the superficial layer. Compared to con-
trols, adult CKO mice had fewer superficial chondrocytes (11.3% of WT), lower
cartilage surface stiffness (28.7% of WT), and less boundary lubricant secretion
and developed early OA symptoms (Mankin: WTZ1.20.3; Wa5Z1.60.4
CKOZ6.80.5). In culture, activating EGFR is critical for maintaining chondrocyte
numbers, preventing hypertrophy, and promoting Prg4 expression in an EGFR-
dependent manner. After DMM, CKO mice quickly developed the most severe OA
phenotype including a complete loss of cartilage at the medial side (Mankin:
WTZ60.5; Wa5Z11.50.5 CKOZ14.00.0) and an increase in joint pain (Paw
Withdrawal Threshold: CKOZ29.7% of WT). They also developed subchondral
bone sclerosis precisely under the cartilage damage area (4.5 folds of WT), owing
to elevated mechanical stress (12.6 folds of WT) and a reduction of sclerostin in
the subchondral bone plate.
Conclusions: Our work establishes EGFR signalling as a novel and important regu-
lator of articular cartilage that prevents osteoarthritis initiation and elucidates the
mechanism of subchondral bone symptoms associated with late osteoarthritis.
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Introduction: Knees with history of tears in the anterior cruciate ligament (ACL)
are more prone to develop post-traumatic osteoarthritis (PTOA) [1]. However,
there are no preventive treatments available for this disease, since factors that
can be used to predict and monitor the degeneration in ACL deficient knees are
still under investigation. Recent studies indicated that SDF-1 levels in synovial
fluids (SF) are elevated in OA joints and are positively correlated with radiographic
severity of knee OA [2]. Based on this finding, we hypothesised that levels of SDF-
1a in SF from patients with more severe ACL injuries may be higher than those from
patients with less severe injuries.
Subjects & Methods: SF samples (N Z 96) were collected from patients (35 fe-
males, 61 males, age ranging from 14 to 55 years old) with ACL ruptures immedi-
ately prior to the revision surgery. Based on the injury duration (ID) (the length of
time between injury and surgery), those samples were categorised into 3 groups:
acute (ID  1.0 months), sub-acute (1.0 months < ID  3.0 months), and chronic
(ID > 3.0 months). The level of total proteins in supernatants was measured
with a bicinchoninic acid assay. The content of SDF-1a was quantitated with a hu-
man specific solid phase sandwich enzyme-linked immunosorbent assay. The dif-
ference between groups was compared with an unpaired Student t-test.
Results: The acute group showed the highest total protein level in SF (mean 
S.D.: 32.8  7.4 mg/mL; median: 33.6 mg/mL; N Z 47), which was followed by
the sub-acute group (30.3  13.9 mg/mL; 26.4 mg/mL; 31) and then by the chronic
group (23.3  10.9 mg/mL; 21.9 mg/mL; 18). The difference in the level of total
proteins between the acute group and the chronic group was extremely statisti-
cally significant (P Z 0.0001). The same pattern was observed in SDF-1a content
analysis: 3,240.4  1,339.4 pg/mL (median: 3,158.8 pg/mL) in the acute group,
2,976.9  889.2 pg/mL (median: 3,024.5 pg/mL) in the sub-acute group, and
2,392.6  1,241.7 pg/mL (median: 2,084.0 pg/mL) in the chronic group. The
average level of SDF-1a in the acute group was also significantly higher than
that in the chronic group (P Z 0.023).
Discussion & Conclusion: Our results from analysing SF samples from patients
with ACL injuries indicated that the levels of total proteins and SDF-1a in the
acute group were markedly higher than those in the chronic group, which sup-
ports our hypothesis. Presumably, patients in the acute group with a shorter
ID may sustain more severe ACL injuries than the ones in the chronic group
with a longer ID. The injury severity may positively correlate with the possibility
of PTOA onset in the injured knees [3]. Based on this theory, therapies targeting
SDF-1a might be effective in preventing the development of PTOA in ACL defi-
cient knees.
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